{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:17:58Z","timestamp":1791220678605,"version":"4.1.0"},"reference-count":184,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":504,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.bbadis.2011.11.005","type":"journal-article","created":{"date-parts":[[2011,11,15]],"date-time":"2011-11-15T23:36:41Z","timestamp":1321400201000},"page":"370-379","source":"Crossref","is-referenced-by-count":153,"title":["PET amyloid-beta imaging in preclinical Alzheimer's disease"],"prefix":"10.1016","volume":"1822","author":[{"given":"Andrei G.","family":"Vlassenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie L.S.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2011.11.005_bb0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population: prevalence estimates using the 2000 census","volume":"60","author":"Hebert","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0925","doi-asserted-by":"crossref","first-page":"77sr71","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer's disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuron.2008.06.008","article-title":"Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks","volume":"59","author":"Kuchibhotla","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \"preclinical\" Alzheimer's disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0025","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.58.9.1395","article-title":"Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease","volume":"58","author":"Price","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0030","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neuint.2006.10.007","article-title":"Glutamate-glutamine cycling in Alzheimer's disease","volume":"50","author":"Walton","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0306-4522(01)00169-5","article-title":"The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease","volume":"105","author":"Dickson","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0045","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","article-title":"Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains","volume":"271","author":"Kuo","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0055","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.bcp.2004.12.015","article-title":"Emerging prospects for the disease-modifying treatment of Alzheimer's disease","volume":"69","author":"Walker","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","article-title":"Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease","volume":"14","author":"Ferrer","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000148590.39911.DF","article-title":"Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease","volume":"64","author":"Masliah","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0070","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43)","volume":"13","author":"Iwatsubo","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0085","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0090","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0095","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0110","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","article-title":"Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis","volume":"60","author":"Small","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0115","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer's disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0930","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archneurol.2011.70","article-title":"Amyloid-dependent and amyloid-independent stages of Alzheimer disease","volume":"68","author":"Hyman","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/1565","article-title":"Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau","volume":"1","author":"Hardy","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev.neuro.21.1.479","article-title":"Mutant genes in familial Alzheimer's disease and transgenic models","volume":"21","author":"Price","year":"1998","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/nbdi.1996.0016","article-title":"The gene defects responsible for familial Alzheimer's disease","volume":"3","author":"Tanzi","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0140","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer's disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0145","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0150","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.21099","article-title":"Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation","volume":"61","author":"Kauwe","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0160","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2007.11.083","article-title":"Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis","volume":"585","author":"Marcello","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0170","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1073\/pnas.1010461107","article-title":"Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition","volume":"107","author":"Vlassenko","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0175","doi-asserted-by":"crossref","first-page":"17757","DOI":"10.1073\/pnas.1010459107","article-title":"Regional aerobic glycolysis in the human brain","volume":"107","author":"Vaishnavi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/JMN:17:2:101","article-title":"Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease","volume":"17","author":"Morris","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0935","doi-asserted-by":"crossref","unstructured":"Y.S. Shim, J.C. Morris, Biomarkers predicting Alzheimer's disease in cognitively normal aging, J Clin Neurol 7 60\u201368.","DOI":"10.3988\/jcn.2011.7.2.60"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0190","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tins.2011.05.005","article-title":"Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia","volume":"34","author":"Ewers","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/MN:24:1-3:087","article-title":"CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease","volume":"24","author":"Blennow","year":"2001","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0210","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0215","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease","volume":"1","author":"Fagan","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0220","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/WNL.58.11.1622","article-title":"Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration","volume":"58","author":"Riemenschneider","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0225","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s007020070079","article-title":"CSF levels of tau, beta-amyloid(1\u201342) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging","volume":"107","author":"Sjogren","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0230","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","article-title":"Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?","volume":"60","author":"Clark","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0235","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/01.wnl.0000256043.50901.e3","article-title":"Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker","volume":"68","author":"Bateman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0240","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased beta-amyloid1\u201342 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease","volume":"289","author":"Sunderland","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0245","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0250","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(98)00122-1","article-title":"Combination assay of CSF tau, A beta 1\u201340 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease","volume":"158","author":"Shoji","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0255","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ana.1054","article-title":"Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease","volume":"50","author":"Itoh","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0260","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0265","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0270","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archpsyc.61.1.95","article-title":"Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study","volume":"61","author":"Hampel","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0275","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archneur.59.8.1267","article-title":"Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231","volume":"59","author":"Buerger","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0280","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.wnl.0000267428.62582.aa","article-title":"CSF tau\/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0285","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/WCO.0b013e3283168e1a","article-title":"The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation","volume":"21","author":"Klunk","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0290","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.semnuclmed.2011.02.005","article-title":"Positron emission tomography radiopharmaceuticals for imaging brain beta-amyloid","volume":"41","author":"Vallabhajosula","year":"2011","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0295","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1155\/2009\/609839","article-title":"Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo","volume":"21","author":"Rabinovici","year":"2009","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0940","doi-asserted-by":"crossref","first-page":"RC189","DOI":"10.1523\/JNEUROSCI.21-24-j0004.2001","article-title":"Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease","volume":"21","author":"Agdeppa","year":"2001","journal-title":"J.Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0305","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","article-title":"Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease","volume":"10","author":"Shoghi-Jadid","year":"2002","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0310","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/syn.20508","article-title":"Amyloid imaging in aged and young macaques with [11C]PIB and [18F]FDDNP","volume":"62","author":"Noda","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0315","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","article-title":"PET of brain amyloid and tau in mild cognitive impairment","volume":"355","author":"Small","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0320","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1471-4159.2009.05996.x","article-title":"Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies","volume":"109","author":"Thompson","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0325","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0969-8051(03)00049-0","article-title":"11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease","volume":"30","author":"Ono","year":"2003","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0330","first-page":"584","article-title":"In vivo imaging of Alzheimer disease \u00e1-amyloid with [ 1 1 C]SB-13 PET","volume":"12","author":"Verhoef","year":"2004","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0335","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","article-title":"Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism","volume":"7","author":"Rowe","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0340","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2967\/jnumed.108.060756","article-title":"Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging","volume":"50","author":"Koole","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0345","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/jm901039z","article-title":"18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective","volume":"53","author":"Kung","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0350","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nucmedbio.2006.10.003","article-title":"18F-labeled styrylpyridines as PET agents for amyloid plaque imaging","volume":"34","author":"Zhang","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0355","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2967\/jnumed.109.065284","article-title":"Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain","volume":"50","author":"Choi","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0360","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.nucmedbio.2010.05.001","article-title":"Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer's disease","volume":"37","author":"Liu","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0365","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45","volume":"51","author":"Wong","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0370","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nucmedbio.2010.02.003","article-title":"Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent\u2013a pilot study","volume":"37","author":"Lin","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0375","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0380","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0006-8993(02)03436-4","article-title":"IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques","volume":"956","author":"Kung","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0385","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/jm020351j","article-title":"Structure\u2013activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain","volume":"46","author":"Zhuang","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0390","first-page":"748","article-title":"Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease","volume":"47","author":"Newberg","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0395","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/bc8003292","article-title":"Novel radioiodinated aurones as probes for SPECT imaging of beta-amyloid plaques in the brain","volume":"20","author":"Maya","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0400","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0405","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(04)00853-1","article-title":"PET imaging of amyloid in Alzheimer's disease","volume":"3","author":"Nordberg","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0410","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer's disease","volume":"129","author":"Engler","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0415","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuroimage.2007.09.020","article-title":"Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease","volume":"39","author":"Drzezga","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0420","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","article-title":"[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease","volume":"67","author":"Mintun","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0425","first-page":"1959","article-title":"Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis","volume":"46","author":"Lopresti","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0430","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm030026b","article-title":"Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents","volume":"46","author":"Mathis","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0435","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","article-title":"Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B","volume":"25","author":"Price","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0440","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2967\/jnumed.108.055756","article-title":"Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172","volume":"50","author":"O'Keefe","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0445","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","article-title":"Distribution volume ratios without blood sampling from graphical analysis of PET data","volume":"16","author":"Logan","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0450","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2967\/jnumed.107.049932","article-title":"Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease","volume":"49","author":"Mikhno","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0455","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.acra.2008.07.006","article-title":"Automated (11)C-PiB standardized uptake value ratio","volume":"15","author":"Raniga","year":"2008","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0460","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2967\/jnumed.108.057612","article-title":"Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements","volume":"50","author":"McNamee","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0465","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00259-008-0986-8","article-title":"Image-derived input functions for PET brain studies","volume":"36","author":"Mourik","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0470","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0475","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0480","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0485","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.biopsych.2009.09.012","article-title":"Cortical binding of Pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease","volume":"67","author":"Hinrichs","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0490","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archneurol.2011.77","article-title":"Longitudinal patterns of {beta}-amyloid deposition in nondemented older adults","volume":"68","author":"Sojkova","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0495","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0500","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cercor\/bhg087","article-title":"Automatically parcellating the human cerebral cortex","volume":"14","author":"Fischl","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0505","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0510","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3233\/JAD-2010-1401","article-title":"Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease","volume":"20","author":"Lehmann","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0515","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/hbm.20934","article-title":"Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease","volume":"31","author":"Mueller","year":"2010","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0945","doi-asserted-by":"crossref","unstructured":"J. Fortea, R. Sala-Llonch, D. Bartres-Faz, A. Llado, C. Sole-Padulles, B. Bosch, A. Antonell, J. Olives, R. Sanchez-Valle, J.L. Molinuevo, L. Rami, Cognitively preserved subjects with transitional cerebrospinal fluid ss-amyloid 1\u201342 values have thicker cortex in Alzheimer's disease vulnerable areas, Biol Psychiatry 70 183\u2013190.","DOI":"10.1016\/j.biopsych.2011.02.017"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0525","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ana.22333","article-title":"Amyloid-beta associated cortical thinning in clinically normal elderly","volume":"69","author":"Becker","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0950","doi-asserted-by":"crossref","unstructured":"T.M. Seibert, J.B. Brewer, Default network correlations analyzed on native surfaces, J Neurosci Methods 198 301\u2013311.","DOI":"10.1016\/j.jneumeth.2011.04.010"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0535","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/j.jalz.2011.05.637","article-title":"FreeSurfer regional analysis of beta-amyloid deposition with [11C]PIB positron emission tomography","volume":"7","author":"Su","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0540","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0545","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archneur.64.3.431","article-title":"Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report","volume":"64","author":"Bacskai","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0550","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.65.10.noc80013","article-title":"Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B","volume":"65","author":"Leinonen","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0555","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neuint.2008.12.016","article-title":"[(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients","volume":"54","author":"Svedberg","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0560","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1523\/JNEUROSCI.23-06-02086.2003","article-title":"The binding of 2-(4\u2032-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component","volume":"23","author":"Klunk","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0565","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/brain\/awm191","article-title":"PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis","volume":"130","author":"Lockhart","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0570","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.21164","article-title":"Imaging of amyloid burden and distribution in cerebral amyloid angiopathy","volume":"62","author":"Johnson","year":"2007","journal-title":"Ann. Neurol."},{"issue":"Supplement 2","key":"10.1016\/j.bbadis.2011.11.005_bb0955","first-page":"56","article-title":"Comparison of the amyloid imaging agents [F-18]3\u2032-F-PIB and [C-11]PIB in Alzheimer's disease and control subjects","volume":"48","author":"Mathis","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0580","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bmcl.2008.12.069","article-title":"Synthesis of 18F-labelled 2-(4\u2032-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB","volume":"19","author":"Serdons","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0585","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.wad.0000213815.20177.19","article-title":"Cognitive reserve and Alzheimer disease","volume":"20","author":"Stern","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0590","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/0891988705281869","article-title":"Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression","volume":"18","author":"Mortimer","year":"2005","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0595","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archneur.65.11.1467","article-title":"Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake","volume":"65","author":"Roe","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0600","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0197-4580(91)90006-6","article-title":"The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease","volume":"12","author":"Price","year":"1991","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0605","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1212\/WNL.46.3.707","article-title":"Cerebral amyloid deposition and diffuse plaques in \"normal\" aging: evidence for presymptomatic and very mild Alzheimer's disease","volume":"46","author":"Morris","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0610","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneur.62.5.758","article-title":"Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study","volume":"62","author":"Galvin","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0615","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0960","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.neuropsychologia.2011.04.012","article-title":"Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study","volume":"49","author":"Pike","year":"2011","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0625","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease","volume":"30","author":"Price","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0630","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0635","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.neuropsychologia.2008.02.008","article-title":"Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease","volume":"46","author":"Villemagne","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0640","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","article-title":"Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees","volume":"27","author":"Klunk","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0645","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archneur.65.4.540","article-title":"Carbon 11-labeled Pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication","volume":"65","author":"Remes","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0650","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archneurol.2009.285","article-title":"High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types","volume":"66","author":"Villemagne","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0655","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/WNL.0b013e3181bacf1b","article-title":"Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls","volume":"73","author":"Scheinin","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0660","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0665","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0670","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0675","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","article-title":"Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE","volume":"83","author":"Bertram","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0680","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0685","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(94)92557-7","article-title":"Protection against Alzheimer's disease with apoE epsilon 2","volume":"343","author":"Talbot","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0690","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/372092a0","article-title":"Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments","volume":"372","author":"Ma","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0695","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","article-title":"ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo","volume":"41","author":"DeMattos","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0700","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0705","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0710","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","article-title":"Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease","volume":"9","author":"Fagan","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0715","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","article-title":"Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions","volume":"11","author":"Rebeck","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0720","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0725","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM199511093331902","article-title":"Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein","volume":"333","author":"Polvikoski","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0730","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1212\/01.WNL.0000042478.08543.F7","article-title":"Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease","volume":"60","author":"Bennett","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0735","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.0b013e3181a2e8d0","article-title":"Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease","volume":"72","author":"Drzezga","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0740","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0745","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archgenpsychiatry.2008.516","article-title":"Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia","volume":"66","author":"Small","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0750","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archneurol.2009.269","article-title":"Pittsburgh Compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease","volume":"66","author":"Morris","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0755","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","article-title":"Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly","volume":"65","author":"Fagan","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0760","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archneurol.2009.59","article-title":"Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings","volume":"66","author":"Petrie","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0765","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archneurol.2009.272","article-title":"Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition","volume":"66","author":"Storandt","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0770","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1212\/WNL.0b013e3181c918b5","article-title":"Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia","volume":"74","author":"Bourgeat","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0775","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.neuroimage.2010.10.027","article-title":"beta-Amyloid affects frontal and posterior brain networks in normal aging","volume":"54","author":"Oh","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0780","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","article-title":"The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals","volume":"19","author":"Dickerson","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0965","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.biopsych.2009.08.024","article-title":"Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly","volume":"67","author":"Sheline","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0790","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2009.07.003","article-title":"Amyloid deposition is associated with impaired default network function in older persons without dementia","volume":"63","author":"Sperling","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0795","doi-asserted-by":"crossref","first-page":"12686","DOI":"10.1523\/JNEUROSCI.3189-09.2009","article-title":"Disruption of functional connectivity in clinically normal older adults harboring amyloid burden","volume":"29","author":"Hedden","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0970","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/cercor\/bhr025","article-title":"Relationships between beta-amyloid and functional connectivity in different components of the default mode network in aging","volume":"21","author":"Mormino","year":"2011","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0975","article-title":"Age and amyloid-related alterations in default network habituation to stimulus repetition","author":"Vannini","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0810","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.neuropsychologia.2011.06.006","article-title":"Face-name associative memory performance is related to amyloid burden in normal elderly","volume":"49","author":"Rentz","year":"2011","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0815","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/brain\/awq383","article-title":"Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease","volume":"134","author":"Chetelat","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0820","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneurol.2007.27","article-title":"Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve","volume":"65","author":"Fotenos","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0825","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ana.21904","article-title":"Cognition, reserve, and amyloid deposition in normal aging","volume":"67","author":"Rentz","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0830","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.22096","article-title":"Exercise and Alzheimer's disease biomarkers in cognitively normal older adults","volume":"68","author":"Liang","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0835","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrn2298","article-title":"Be smart, exercise your heart: exercise effects on brain and cognition","volume":"9","author":"Hillman","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0840","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/aje\/kwi092","article-title":"Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study","volume":"161","author":"Podewils","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0845","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jalz.2007.01.003","article-title":"Physical activity and the maintenance of cognitive function","volume":"3","author":"Rockwood","year":"2007","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0850","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1523\/JNEUROSCI.0496-05.2005","article-title":"Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease","volume":"25","author":"Adlard","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0855","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1002\/jnr.22075","article-title":"Repression of tau hyperphosphorylation by chronic endurance exercise in aged transgenic mouse model of tauopathies","volume":"87","author":"Leem","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0860","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.biopsych.2006.04.004","article-title":"Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease","volume":"60","author":"Wolf","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0865","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/WAD.0b013e31819cb8a2","article-title":"Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease","volume":"23","author":"Honea","year":"2009","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0870","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/WNL.0b013e3181e620f4","article-title":"Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept","volume":"75","author":"Roe","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0875","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1740774510392391","article-title":"Designing clinical trials to test disease-modifying agents: application to the treatment trials of Alzheimer's disease","volume":"8","author":"Xiong","year":"2011","journal-title":"Clin. Trials"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0880","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awn320","article-title":"Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects","volume":"132","author":"Mormino","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0885","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/WNL.0b013e3181af79e5","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0890","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0895","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ana.21953","article-title":"Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease","volume":"67","author":"Vemuri","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0900","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/brain\/awr049","article-title":"Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition","volume":"134","author":"Vemuri","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.11.005_bb0905","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jalz.2010.03.004","article-title":"Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative","volume":"6","author":"Jack","year":"2010","journal-title":"Alzheimers Dement."},{"issue":"202\u2013211","key":"10.1016\/j.bbadis.2011.11.005_bb0980","first-page":"e207","article-title":"The Alzheimer's disease neuroimaging initiative: progress report and future plans","volume":"6","author":"Weiner","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0985","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archneurol.2011.123","article-title":"Longitudinal change of biomarkers in cognitive decline","volume":"68","author":"Lo","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.005_bb0920","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt59","article-title":"Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease","volume":"3","author":"Bateman","year":"2011","journal-title":"Alzheimers Res. Ther."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911002559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911002559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T15:02:14Z","timestamp":1713106934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443911002559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":184,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0925443911002559"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2011.11.005","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}